[ Price : $8.95]
CDER director Patrizia Cavazzoni puts a positive spin on drug inspections, user fee goals, and enforcement and compliance activiti...[ Price : $8.95]
FDA approves a Rhythm Pharmaceuticals supplemental NDA for Imcivree (setmelanotide) injection, indicated for chronic weight manage...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Voluntary Consensus Standards Recognition Program for Regen...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Administrative Procedures for Clinical ...[ Price : $8.95]
FDA says its Psychopharmacologic Drugs Advisory Committee will consider whether data from Acadia Pharmaceutical trials support an ...[ Price : $8.95]
Four Alston & Bird attorneys describe some of the major items in the PDUFA 7 reauthorization legislation that has bipartisan suppo...[ Price : $8.95]
Pfizer says it will stop enrolling standard risk patients in the EPIC-SR trial of its anti-Covid therapy Paxlovid and submit data ...[ Price : $8.95]
The Senate Health, Education, Labor and Pensions Committee passes the FDA Safety and Landmark Advancements (FDASLA) Act, which rea...